Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. ConvaTec swoops in to lure KCI away at the last minute
Apax Partners may have a rival for its sweetheart, Kinetic Concepts Inc. (NYSE:KCI), after news broke that KCI rival ConvaTec Inc. trumped the private equity player’s $6.3 billion bid for the wound care giant.
2. JNJ outsources the DePuy recall
Johnson & Johnson’s (NYSE:JNJ) decision to hire an outside firm to manage the high-profile recall of its DePuy ASR hip implant raises a few eyebrows.
1. Recalling the Sprint Fidelis lead
Former Medtronic CEO Bill Hawkins reminisces about facing one of the toughest decisions in his tenure – recalling the med-tech giant’s top product, the Sprint Fidelis lead.